Department of Vascular Surgery, Sahlgrenska University Hospital and Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Department of Vascular Surgery, Sahlgrenska University Hospital and Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Eur J Vasc Endovasc Surg. 2023 Aug;66(2):245-251. doi: 10.1016/j.ejvs.2023.05.014. Epub 2023 May 16.
Patients with chronic limb threatening ischaemia (CLTI) suffer from pain and non-healing ulcers, which impact negatively on both their physical and mental health. While maintaining and improving quality of life is a principal aim with all treatments, little is known about the health related quality of life (HRQoL) of CLTI patients and how revascularisation procedures impact on HRQoL endpoints. The aim of this study was to investigate disease specific HRQoL before and after revascularisation in patients with CLTI undergoing femoropopliteal revascularisation.
HRQoL was prospectively analysed in 190 CLTI patients with main atherosclerotic target lesions in the femoropopliteal segment, who were planned for endovascular or open revascularisation. The choice of revascularisation method was made by the vascular team, represented by both open and endovascular expertise. The Vascular Quality of Life (VascuQoL) questionnaire was used to assess disease specific HRQoL before revascularisation and one month, one year, and two years after the procedure. Main endpoints were mean VascuQoL score changes, effect sizes of observed changes and the proportion reaching a minimally important difference (half a standard deviation change from baseline) during two years after revascularisation.
Patient reported VascuQoL scores were low at baseline (mean 2.68, 95% CI 1.18 - 4.17). After revascularisation, the mean VascuQoL score improved statistically significantly over time, with the largest improvement observed after one year (difference from baseline 2.02, 95% CI 1.75 - 2.29; p < .001). No differences in HRQoL change over time were observed between patients treated with endovascular approaches compared with bypass surgery. Approximately half the patients reached the minimally important threshold at one year (53%), which was largely maintained also at two years (41%).
While CLTI profoundly affected HRQoL, a large and clinically meaningful HRQoL increase was observed after revascularisation. This confirms the value of CLTI revascularisation on HRQoL and underlines the importance of including patient reported outcomes when evaluating revascularisation procedures in CLTI patients.
患有慢性肢体威胁性缺血(CLTI)的患者会遭受疼痛和不愈合的溃疡,这对他们的身心健康都有负面影响。虽然维持和改善生活质量是所有治疗的主要目标,但对于 CLTI 患者的健康相关生活质量(HRQoL)以及血管重建术如何影响 HRQoL 终点知之甚少。本研究旨在调查接受股腘血管重建术的 CLTI 患者在血管重建术前和术后的特定疾病 HRQoL。
前瞻性分析了 190 名 CLTI 患者的 HRQoL,这些患者的主要动脉粥样硬化靶病变位于股腘段,计划进行血管内或开放血管重建术。血管团队(包括开放和血管内专业知识)选择了血管重建方法。使用血管生活质量(VascuQoL)问卷评估血管重建术前以及术后 1 个月、1 年和 2 年的特定疾病 HRQoL。主要终点是平均 VascuQoL 评分变化、观察到的变化的效应大小以及在血管重建术后 2 年内达到最小重要差异(从基线变化半标准差)的比例。
患者报告的 VascuQoL 评分在基线时较低(平均 2.68,95%CI 1.18-4.17)。血管重建术后,VascuQoL 评分随时间呈统计学显著改善,最大改善发生在术后 1 年(与基线相比的差异为 2.02,95%CI 1.75-2.29;p<.001)。与旁路手术相比,接受血管内治疗的患者在 HRQoL 随时间的变化方面没有差异。大约一半的患者在术后 1 年达到了最小重要阈值(53%),这一比例在术后 2 年也基本保持(41%)。
虽然 CLTI 严重影响 HRQoL,但血管重建术后观察到 HRQoL 显著增加。这证实了 CLTI 血管重建术对 HRQoL 的价值,并强调了在评估 CLTI 患者的血管重建术时纳入患者报告的结果的重要性。